ADARx Pharmaceuticals Raises $200M in Series C Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Ricky Sun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Proceeds to Further Advance Company’s Lead Clinical ProgramsSAN DIEGO--(BUSINESS WIRE)--ADARx Pharmaceuticals, Inc. (“ADARx” or “the Company”), a clinical stage biotechnology company developing next generation RNA therapeutics, today announced the successful close of an oversubscribed $200 million Series C financing...
SUBSCRIPTION AGREEMENT Pharvaris N.V. Emmy Noetherweg 2 2333 BK Leiden The Netherlands Ladies and Gentlemen: ... | June 20, 2023
Investegate announcements from Arix Bioscience PLC, Portfolio company Disc Medicine announces $62.5 million financing
San Ramon, California (PRWEB) October 28, 2022 -- Oct 28, 2022Ultipa, a Silicon Valley veterans founded next-generation graph database and killer-app